Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
about
Transcriptional Targeting in Cancer Gene Therapyα-Fetoprotein promoter-driven Cre/LoxP-switched RNA interference for hepatocellular carcinoma tissue-specific target therapy.Generation of a tumor- and tissue-specific episomal non-viral vector system.Safety and pharmacokinetics of recombinant human hepatocyte growth factor (rh-HGF) in patients with fulminant hepatitis: a phase I/II clinical trial, following preclinical studies to ensure safety.Current advances in retroviral gene therapy.High-level expression by tissue/cancer-specific promoter with strict specificity using a single-adenoviral vector.Utilizing alpha-fetoprotein expression to enhance oncolytic viral therapy in hepatocellular carcinoma.Construction of a targeting adenoviral vector carrying AFP promoter for expressing EGFP gene in AFP-producing hepatocarcinoma cell.Selective inhibition of hepatoma cells using diphtheria toxin A under the control of the promoter/enhancer region of the human alpha-fetoprotein gene.In vivo retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for adult T cell leukemia in a rat model.TGF- β Signaling Cooperates with AT Motif-Binding Factor-1 for Repression of the α -Fetoprotein Promoter.Suicide gene therapy for chemically induced rat bladder tumor entailing instillation of adenoviral vectors.A hypoxia- and telomerase-responsive oncolytic adenovirus expressing secretable trimeric TRAIL triggers tumour-specific apoptosis and promotes viral dispersion in TRAIL-resistant glioblastoma.
P2860
Q24791038-9D9E0A14-A263-4D31-89FB-F95A8B945A0FQ34611324-75F05855-E7B2-4617-89FF-22DE585B50B0Q34756391-F0C10828-D934-45F1-8AB2-F09597369395Q35038572-A6055C94-84AA-49C4-A691-F88E76432F4CQ35237554-46D5818E-CDBA-4EAF-B090-D3E019366092Q39635650-B71468F9-A15F-4944-8DF1-425DEFC57F3FQ40512526-DA411D10-A261-4DEC-83C8-5C8D27645599Q40600361-BF6E09C5-9843-405E-9544-24D5E27627BAQ40887725-21C838C0-25FC-4022-B3FA-9F80165717C1Q41111406-06CE256A-B322-4614-ACCE-FDB3D3CFD18DQ42742346-AFCFC53B-DF71-43B6-B613-A4A8DF8D31A7Q43619717-2409999C-F5DD-44A4-95FE-3F13D881D17AQ47549547-3582E735-6295-4269-970D-093909EDE7F3
P2860
Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Gene therapy for hepatoma cell ...... pha-fetoprotein gene promoter.
@ast
Gene therapy for hepatoma cell ...... pha-fetoprotein gene promoter.
@en
Gene therapy for hepatoma cell ...... pha-fetoprotein gene promoter.
@nl
type
label
Gene therapy for hepatoma cell ...... pha-fetoprotein gene promoter.
@ast
Gene therapy for hepatoma cell ...... pha-fetoprotein gene promoter.
@en
Gene therapy for hepatoma cell ...... pha-fetoprotein gene promoter.
@nl
prefLabel
Gene therapy for hepatoma cell ...... pha-fetoprotein gene promoter.
@ast
Gene therapy for hepatoma cell ...... pha-fetoprotein gene promoter.
@en
Gene therapy for hepatoma cell ...... pha-fetoprotein gene promoter.
@nl
P2093
P1433
P1476
Gene therapy for hepatoma cell ...... pha-fetoprotein gene promoter.
@en
P2093
Nagataki S
P304
P407
P577
1995-07-01T00:00:00Z